Collegium Pharmaceutical, Inc.

NASDAQ:COLL

29.46 (USD) • At close March 14, 2025
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2024 Q42024 Q32024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q12018 Q42018 Q32018 Q22018 Q12017 Q42017 Q32017 Q22017 Q12016 Q42016 Q32016 Q22016 Q12015 Q42015 Q32015 Q22015 Q12014 Q42014 Q32014 Q22014 Q1
Revenue 181.949159.301145.276144.923149.745136.709135.546144.767129.62127.013123.54983.75127.36278.84382.94287.72176.27179.17678.05876.51174.20372.94275.0474.51673.42770.17673.06163.74910.79411.953.562.1721.3030.4080000000000
Cost of Revenue 83.66162.50754.4753.46755.11556.39861.7267.36579.83168.17471.18535.25528.69532.7332.70332.12331.97930.98329.69437.52449.08846.75448.65449.16429.72646.00746.83843.1061.0940.5530.5770.3710.1840.0290000000000
Gross Profit 98.28896.79490.80691.45694.6380.31173.82677.40249.78958.83952.36448.496-1.33346.11350.23955.59844.29248.19348.36438.98725.11526.18826.38625.35243.70124.16926.22320.6439.711.3972.9831.8011.1190.3790000000000
Gross Profit Ratio 0.540.6080.6250.6310.6320.5870.5450.5350.3840.4630.4240.579-0.0490.5850.6060.6340.5810.6090.620.510.3380.3590.3520.340.5950.3440.3590.3240.8990.9540.8380.8290.8590.9290000000000
Reseach & Development Expenses 00000000-3.983003.9831.6091.453.4622.932.4722.1412.4932.6662.3982.4912.4592.9922.2491.9072.2372.2682.1942.0692.1792.133.3313.2544.3014.0621.5313.3581.6411.4452.3075.8183.5653.269
General & Administrative Expenses 000025.53600026.28900022.416000113.83200000000000000000007.9055.9072.9342.1851.020.6870.5230.475
Selling & Marketing Expenses 00007.40600011.7430004.186000-87.00826.42629.32231.2625.0930.07228.93532.35230.45133.44831.27931.58225.08922.75822.06222.84725.36723.56720.17311.52500000000
SG&A 63.09161.95543.33541.98232.94235.29838.19352.77538.03238.37241.25454.52826.60230.51430.36831.47626.82426.42629.32231.2625.0930.07228.93532.35230.45133.44831.27931.58225.08922.75822.06222.84725.36723.56720.17311.5257.9055.9072.9342.1851.020.6870.5230.475
Other Expenses -2.91400000003.98300014.0290009.7720000000000000000.02000-0.0890000000
Operating Expenses 60.17761.95543.33541.98232.94235.29838.19352.77538.03238.37241.25458.51128.21131.96433.8334.40629.29628.56731.81533.92627.48832.56331.39435.34432.735.35533.51633.8527.28324.82724.24124.97728.69826.82124.47415.5879.4369.2654.5753.633.3276.5054.0883.744
Operating Income 38.11134.83947.47149.47461.68845.01335.63324.627-30.3220.46711.11-10.011-34.12214.14916.40921.19214.99619.62616.5495.061-2.373-6.375-5.008-9.99211.001-11.186-7.293-13.207-17.583-13.43-21.258-23.176-27.579-26.442-24.474-15.587-9.436-9.265-4.575-3.63-3.327-6.505-4.088-3.744
Operating Income Ratio 0.2090.2190.3270.3410.4120.3290.2630.17-0.2340.1610.09-0.12-1.2470.1790.1980.2420.1970.2480.2120.066-0.032-0.087-0.067-0.1340.15-0.159-0.1-0.207-1.629-1.124-5.971-10.67-21.166-64.8090000000000
Total Other Income Expenses Net -20.842-19.259-18.374-12.852-14.978-16.23-17.836-42.184-19.548-19.035-17.756-5.827-4.754-5.112-5.418-5.718-7.734-8.06-8.245-4.6110.1720.2660.2960.292-1.915-5.316-5.767-5.4450.180.1670.1370.0980.02-0.002-0.046-0.066-0.089-0.097-0.099-0.064-0.142-0.051-0.029-0.029
Income Before Tax 17.26915.5829.09736.62246.7128.78317.797-17.557-7.7911.432-6.646-15.842-38.8769.03710.99115.4747.26211.5668.3040.45-2.201-6.109-4.712-9.79.086-16.502-13.06-18.652-17.403-13.263-21.121-23.078-27.559-26.444-24.52-15.653-9.525-9.362-4.674-3.694-3.469-6.556-4.117-3.773
Income Before Tax Ratio 0.0950.0980.20.2530.3120.2110.131-0.121-0.060.011-0.054-0.189-1.4210.1150.1330.1760.0950.1460.1060.006-0.03-0.084-0.063-0.130.124-0.235-0.179-0.293-1.612-1.11-5.933-10.625-21.15-64.8140000000000
Income Tax Expense 4.7336.2459.4918.90914.778.1494.79-0.131-0.5920.975-1.455-2.773-13.8420.991-61.852-0.1880.3040.280.2464.6110.211-0.266-0.296-0.2921.9155.8686.1585.7-0.36-0.334-0.274-0.196-0.0190.0020.0460.0660.0890.0970.099-0.0910.1420.0510.0290.029
Net Income 12.5369.33519.60627.71331.9420.63413.007-17.426-7.1990.457-5.191-13.069-25.0348.04672.84315.6626.95811.2868.0580.45-2.201-6.109-4.712-9.79.086-16.502-13.06-18.652-17.403-13.263-21.121-23.078-27.559-26.444-24.52-15.653-9.525-9.362-4.674-3.694-3.469-6.556-4.117-3.773
Net Income Ratio 0.0690.0590.1350.1910.2130.1510.096-0.12-0.0560.004-0.042-0.156-0.9150.1020.8780.1790.0910.1430.1030.006-0.03-0.084-0.063-0.130.124-0.235-0.179-0.293-1.612-1.11-5.933-10.625-21.15-64.8140000000000
EPS 0.390.330.60.860.990.610.38-0.51-0.210.013-0.15-0.39-0.730.232.060.450.20.330.230.01-0.066-0.18-0.14-0.290.27-0.5-0.4-0.57-0.54-0.45-0.72-0.79-1.02-1.13-1.05-0.68-0.46-0.46-0.4-0.19-0.46-0.88-0.55-0.5
EPS Diluted 0.310.270.520.710.820.530.34-0.51-0.210.013-0.15-0.39-0.730.221.790.410.20.320.230.01-0.066-0.18-0.14-0.290.27-0.5-0.4-0.57-0.53-0.45-0.72-0.79-1.02-1.13-1.05-0.68-0.46-0.46-0.4-0.19-0.46-0.88-0.55-0.5
EBITDA 38.11175.72180.15189.395101.45486.65877.9142.04850.99958.4349.5439.785-16.90231.40133.6438.43632.07536.61933.55415.7661.798-2.013-0.617-5.59427.32621.92725.60117.056-17.273-13.131-20.997-22.87-27.283-26.169-24.43-15.544-9.395-9.227-4.529-3.493-3.281-6.459-4.041-3.696
EBITDA Ratio 0.2090.4750.5710.5860.6780.6340.5760.4540.0990.4610.3990.115-1.080.3980.4050.4380.1970.4630.430.206-0.027-0.028-0.008-0.0750.1560.3120.350.268-1.617-1.113-5.937-10.575-21.166-64.140000000000